Mouse Bone Marrow-Derived Mesenchymal Stromal Cells Turn Activated Macrophages into a Regulatory-Like Profile
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
In recent years it has become clear that the therapeutic properties of bone marrow-derived mesenchymal stromal cells (MSC) are related not only to their ability to differentiate into different lineages but also to their capacity to suppress the immune response. We here studied the influence of MSC on macrophage function. Using mouse thioglycolate-elicited peritoneal macrophages (M) stimulated with LPS, we found that MSC markedly suppressed the production of the inflammatory cytokines TNF-alpha, IL-6, IL-12p70 and interferon-gamma while increased the production of IL-10 and IL-12p40. Similar results were observed using supernatants from MSC suggesting that factor(s) constitutively released by MSC are involved. Supporting a role for PGE(2) we observed that acetylsalicylic acid impaired the ability of MSC to inhibit the production of inflammatory cytokines and to stimulate the production of IL-10 by LPS-stimulated M. Moreover, we found that MSC constitutively produce PGE2 at levels able to inhibit the production of TNF-alpha and IL-6 by activated M. MSC also inhibited the up-regulation of CD86 and MHC class II in LPS-stimulated M impairing their ability to activate antigen-specific T CD4+ cells. On the other hand, they stimulated the uptake of apoptotic thymocytes by M. Of note, MSC turned M into cells highly susceptible to infection with the parasite Trypanosoma cruzi increasing more than 5-fold the rate of M infection. Using a model of inflammation triggered by s.c. implantation of glass cylinders, we found that MSC stimulated the recruitment of macrophages which showed a low expression of CD86 and the MHC class II molecule Ia(b) and a high ability to produce IL-10 and IL-12p40, but not IL-12 p70. In summary, our results suggest that MSC switch M into a regulatory profile characterized by a low ability to produce inflammatory cytokines, a high ability to phagocyte apoptotic cells, and a marked increase in their susceptibility to infection by intracellular pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052 · cited 1×
“types such as osteoblasts, chondrocytes and adipocytes [1].”
BackgroundExploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618 · cited 1×
“If apoptotic cells are not efficiently removed they release intracellular constituents able to further increase the course of inflammation, among them, ATP, K ions, uric acid, high-mobility group box 1 protein (HMGB1) and several members of the S100 calciumbinding protein family [55].”
BackgroundAlternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190
Interferon-γ: an overview of signals, mechanisms and functions
Schroder, K., Hertzog, P. J., Ravasi, T., & Hume, D. A. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603252 · Cited by 4,120 · cited 2×
“It is the key cytokine to induce the activation of macrophages by increasing the expression of MHC class II and costimulatory molecules and the production of inflammatory mediators enabling macrophages to display a high anti-microbial and tumoricidal activity [26,27].”
BackgroundMesenchymal stem cells in health and disease
Uccelli, A., Moretta, L., & Pistoia, V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2395 · Cited by 3,746
Current Protocols in Immunology
(2018) · Current Protocols in Immunology · doi:10.1002/(issn)1934-368x · Cited by 3,566
Resolution of inflammation: the beginning programs the end
Serhan, C. N., & Savill, J. (2005) · Nature Immunology · doi:10.1038/ni1276 · Cited by 2,552 · cited 1×
“The clearance of apoptotic cells plays a critical role in the resolution of inflammatory processes [54].”
BackgroundChamberlain, G., Fox, J., Ashton, B., & Middleton, J. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0197 · Cited by 2,381
Cited by
Inflammation, fracture and bone repair
Loi, F., Córdova, L. A., Pajarinen, J., Lin, T.-H., Yao, Z., & Goodman, S. B. (2016) · Bone · doi:10.1016/j.bone.2016.02.020 · Cited by 1,293
Multipotent mesenchymal stromal cells and the innate immune system
Le Blanc, K., & Mougiakakos, D. (2012) · Nature Reviews Immunology · doi:10.1038/nri3209 · Cited by 1,018
Mesenchymal stem cell-macrophage crosstalk and bone healing
Pajarinen, J., Lin, T., Gibon, E., Kohno, Y., Maruyama, M., Nathan, K., Lu, L., Yao, Z., & Goodman, S. B. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2017.12.025 · Cited by 999
Mechanisms of mesenchymal stem/stromal cell function
Spees, J. L., Lee, R. H., & Gregory, C. A. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0363-7 · Cited by 891
Mesenchymal Stem Cells: Mechanisms of Inflammation
Singer, N. G., & Caplan, A. I. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130230 · Cited by 851
Mesenchymal Stem/Stromal Cells (MSCs): Role as Guardians of Inflammation
Prockop, D. J., & Youn Oh, J. (2012) · Molecular Therapy · doi:10.1038/mt.2011.211 · Cited by 816
BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progression
Roccaro, A. M., Sacco, A., Maiso, P., Azab, A. K., Tai, Y.-T., Reagan, M., Azab, F., Flores, L. M., Campigotto, F., Weller, E., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66517 · Cited by 794
Rational Design of Immunomodulatory Hydrogels for Chronic Wound Healing
Kharaziha, M., Baidya, A., & Annabi, N. (2021) · Advanced Materials · doi:10.1002/adma.202100176 · Cited by 721
Mesenchymal Stem Cells: Mechanisms of Immunomodulation and Homing
Yagi, H., Soto-Gutierrez, A., Parekkadan, B., Kitagawa, Y., Tompkins, R. G., Kobayashi, N., & Yarmush, M. L. (2010) · Cell Transplantation · doi:10.3727/096368910x508762 · Cited by 701
Cosenza, S., Ruiz, M., Toupet, K., Jorgensen, C., & Noël, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-15376-8 · Cited by 649
Immune Regulation of Skin Wound Healing: Mechanisms and Novel Therapeutic Targets
Larouche, J., Sheoran, S., Maruyama, K., & Martino, M. M. (2018) · Advances in Wound Care · doi:10.1089/wound.2017.0761 · Cited by 630
Zhang, Q.-Z., Su, W.-R., Shi, S.-H., Wilder-Smith, P., Xiang, A. P., Wong, A., Nguyen, A. L., Kwon, C. W., & Le, A. D. (2010) · Stem Cells · doi:10.1002/stem.503 · Cited by 620
Concise Review: Mesenchymal Stem Cells: From Roots to Boost
Andrzejewska, A., Lukomska, B., & Janowski, M. (2019) · Stem Cells · doi:10.1002/stem.3016 · Cited by 611
Cho, D.-I., Kim, M. R., Jeong, H.-Y., Jeong, H. C., Jeong, M. H., Yoon, S. H., Kim, Y. S., & Ahn, Y. (2014) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.135 · Cited by 541
Mechanisms of mesenchymal stromal cell immunomodulation
English, K. (2013) · Immunology & Cell Biology · doi:10.1038/icb.2012.56 · Cited by 518
de Witte, S. F. H., Luk, F., Sierra Parraga, J. M., Gargesha, M., Merino, A., Korevaar, S. S., Shankar, A. S., O'Flynn, L., Elliman, S. J., Roy, D., et al. (2018) · Stem Cells · doi:10.1002/stem.2779 · Cited by 504
Therapeutic Effects of Human Mesenchymal Stem Cell–derived Microvesicles in Severe Pneumonia in Mice
Monsel, A., Zhu, Y.-G., Gennai, S., Hao, Q., Hu, S., Rouby, J.-J., Rosenzwajg, M., Matthay, M. A., & Lee, J. W. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201410-1765oc · Cited by 457
YlÖstalo, J. H., Bartosh, T. J., Coble, K., & Prockop, D. J. (2012) · STEM CELLS · doi:10.1002/stem.1191 · Cited by 427
Use of Mesenchymal Stem Cells for Therapy of Cardiac Disease
Karantalis, V., & Hare, J. M. (2015) · Circulation Research · doi:10.1161/circresaha.116.303614 · Cited by 425
Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy
Glenn, J. D. (2014) · World Journal of Stem Cells · doi:10.4252/wjsc.v6.i5.526 · Cited by 406
Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cells
Leibacher, J., & Henschler, R. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0271-2 · Cited by 367
ter Huurne, M., Schelbergen, R., Blattes, R., Blom, A., de Munter, W., Grevers, L. C., Jeanson, J., Noël, D., Casteilla, L., Jorgensen, C., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34626 · Cited by 364
Abumaree, M. H., Al Jumah, M. A., Kalionis, B., Jawdat, D., Al Khaldi, A., Abomaray, F. M., Fatani, A. S., Chamley, L. W., & Knawy, B. A. (2013) · Stem Cell Reviews and Reports · doi:10.1007/s12015-013-9455-2 · Cited by 354
Zhao, S.-J., Kong, F.-Q., Jie, J., Li, Q., Liu, H., Xu, A.-D., Yang, Y.-Q., Jiang, B., Wang, D.-D., Zhou, Z.-Q., et al. (2020) · Theranostics · doi:10.7150/thno.36930 · Cited by 332
Ionescu, L., Byrne, R. N., van Haaften, T., Vadivel, A., Alphonse, R. S., Rey-Parra, G. J., Weissmann, G., Hall, A., Eaton, F., & Thébaud, B. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00144.2011 · Cited by 323
Regmi, S., Pathak, S., Kim, J. O., Yong, C. S., & Jeong, J.-H. (2019) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2019.04.002 · Cited by 314
Sharpe, P. T. (2016) · Development · doi:10.1242/dev.134189 · Cited by 310
Stem Cells and Cell Therapies in Lung Biology and Lung Diseases
Weiss, D. J., Kolls, J. K., Ortiz, L. A., Panoskaltsis-Mortari, A., & Prockop, D. J. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200804-037dw · Cited by 309
Mesenchymal stem cells: Amazing remedies for bone and cartilage defects
Kangari, P., Talaei-Khozani, T., Razeghian-Jahromi, I., & Razmkhah, M. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-02001-1 · Cited by 286
Dabrowska, S., Andrzejewska, A., Janowski, M., & Lukomska, B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.591065 · Cited by 282
Luz-Crawford, P., Djouad, F., Toupet, K., Bony, C., Franquesa, M., Hoogduijn, M. J., Jorgensen, C., & Noël, D. (2016) · Stem Cells · doi:10.1002/stem.2254 · Cited by 274
Zhang, J., Liu, X., Wan, C., Liu, Y., Wang, Y., Meng, C., Zhang, Y., & Jiang, C. (2020) · Journal of Clinical Periodontology · doi:10.1111/jcpe.13258 · Cited by 271
Macrophage Subpopulations Are Essential for Infarct Repair With and Without Stem Cell Therapy
Ben-Mordechai, T., Holbova, R., Landa-Rouben, N., Harel-Adar, T., Feinberg, M. S., Abd Elrahman, I., Blum, G., Epstein, F. H., Silman, Z., Cohen, S., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.057 · Cited by 263
Losurdo, M., Pedrazzoli, M., D'Agostino, C., Elia, C. A., Massenzio, F., Lonati, E., Mauri, M., Rizzi, L., Molteni, L., Bresciani, E., et al. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0327 · Cited by 260
Dayan, V., Yannarelli, G., Billia, F., Filomeno, P., Wang, X.-H., Davies, J. E., & Keating, A. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0221-9 · Cited by 249
“BM-derived macrophages were obtained as previously described [18].”
Qi, Y., Jiang, D., Sindrilaru, A., Stegemann, A., Schatz, S., Treiber, N., Rojewski, M., Schrezenmeier, H., Vander Beken, S., Wlaschek, M., et al. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.328 · Cited by 245
The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke
Cunningham, C. J., Redondo-Castro, E., & Allan, S. M. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18776802 · Cited by 242
“Additionally, coculture of MSCs drives the secretome of DCs, T cells, macrophages and NK cells towards anti-inflammatory phenotypes.(117,118) A number of molecules secreted by MSCs including PGE2, TSG-6, TGF-b, HGF and IL10 have been implicated in mediating these immunosuppressive effects.”
BackgroundPhilipp, D., Suhr, L., Wahlers, T., Choi, Y.-H., & Paunel-Görgülü, A. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1039-2 · Cited by 213
Desando, G., Cavallo, C., Sartoni, F., Martini, L., Parrilli, A., Veronesi, F., Fini, M., Giardino, R., Facchini, A., & Grigolo, B. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4156 · Cited by 212
“In recent years, several studies indicate that the therapeutic properties of MSC are due not only to their capacity to differentiate but also to their ability to release growth factors that regulate the immune response in a paracrine manner [12,13].”
BackgroundMesenchymal stem cell‐derived factors: Immuno‐modulatory effects and therapeutic potential
Volarevic, V., Gazdic, M., Simovic Markovic, B., Jovicic, N., Djonov, V., & Arsenijevic, N. (2017) · BioFactors · doi:10.1002/biof.1374 · Cited by 195
“Murine MSCs constitutively produced PGE2 at levels able to induce alternative activation of macrophages [108].”
BackgroundHuang, B., Cheng, X., Wang, H., Huang, W., la Ga hu, Z., Wang, D., Zhang, K., Zhang, H., Xue, Z., Da, Y., et al. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0792-1 · Cited by 183
“For example, MSCs mediate a switch from pro-inflammatory M1-type macrophages to anti-inflammatory M2-type macrophages [17, 18].”
Mesenchymal stem cell-educated macrophages
Eggenhofer, E., & Hoogduijn, M. J. (2012) · Transplantation Research · doi:10.1186/2047-1440-1-12 · Cited by 169
“This effect of MSC is at least partially mediated by soluble mechanisms and prostaglandin E2 (PGE-2) has been indicated to be one of the factors involved [21].”
BackgroundInfluentialPackham, D. K., Fraser, I. R., Kerr, P. G., & Segal, K. R. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.09.011 · Cited by 167
Matthay, M. A., Pati, S., & Lee, J.-W. (2017) · Stem Cells · doi:10.1002/stem.2551 · Cited by 166
Kulesza, A., Paczek, L., & Burdzinska, A. (2023) · Biomedicines · doi:10.3390/biomedicines11020445 · Cited by 163
“Macrophages (MF) ↑ secretion of IL-10 Mice BM-MSCs In vivo [33] ↑ secretion of IL-10; ↓ secretion of TNF, IL-6, IL-10p70 Mice BM-MSCs In vitro [34]”
BackgroundGamblin, A.-L., Brennan, M. A., Renaud, A., Yagita, H., Lézot, F., Heymann, D., Trichet, V., & Layrolle, P. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.08.018 · Cited by 163
Unraveling the Mesenchymal Stromal Cells' Paracrine Immunomodulatory Effects
Fontaine, M. J., Shih, H., Schäfer, R., & Pittenger, M. F. (2016) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2015.11.004 · Cited by 162
Wysoczynki, M., Khan, A., & Bolli, R. (2018) · Circulation Research · doi:10.1161/circresaha.118.313251 · Cited by 161
“MSCs 48 hours after MI in mice induces a macrophage switch toward a reparative phenotype.(112) In rat and pig models of MI,”
BackgroundInflammation, mesenchymal stem cells and bone regeneration
Liu, H., Li, D., Zhang, Y., & Li, M. (2018) · Histochemistry and Cell Biology · doi:10.1007/s00418-018-1643-3 · Cited by 160
Kronsteiner, B., Wolbank, S., Peterbauer, A., Hackl, C., Redl, H., van Griensven, M., & Gabriel, C. (2011) · Stem Cells and Development · doi:10.1089/scd.2011.0031 · Cited by 158
“MSCs have been implicated in suppressing proliferation and influencing effector functions of cells from both the innate and adaptive immune system including natural killercells [15], monocytes [16,17], macrophages [18], dendritic cells [19], B-cells [20], and T-cells [21–24].”
Watanabe, Y., Tsuchiya, A., Seino, S., Kawata, Y., Kojima, Y., Ikarashi, S., Starkey Lewis, P. J., Lu, W.-Y., Kikuta, J., Kawai, H., et al. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.18-0105 · Cited by 155
Inflammation, ageing, and bone regeneration
Gibon, E., Lu, L. Y., Nathan, K., & Goodman, S. B. (2017) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2017.04.002 · Cited by 144
Oh, J. Y., Ko, J. H., Lee, H. J., Yu, J. M., Choi, H., Kim, M. K., Wee, W. R., & Prockop, D. J. (2014) · Stem Cells · doi:10.1002/stem.1608 · Cited by 125
Topographical cues regulate the crosstalk between MSCs and macrophages
Vallés, G., Bensiamar, F., Crespo, L., Arruebo, M., Vilaboa, N., & Saldaña, L. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.028 · Cited by 113
Qiu, X., Liu, S., Zhang, H., Zhu, B., Su, Y., Zheng, C., Tian, R., Wang, M., Kuang, H., Zhao, X., et al. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0821-5 · Cited by 111
Is macrophage polarization important in rheumatoid arthritis?
Wang, Y., Han, C.-C., Cui, D., Li, Y., Ma, Y., & Wei, W. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.07.019 · Cited by 111
Saether, E. E., Chamberlain, C. S., Leiferman, E. M., Kondratko-Mittnacht, J. R., Li, W. J., Brickson, S. L., & Vanderby, R. (2014) · Stem Cell Reviews and Reports · doi:10.1007/s12015-013-9479-7 · Cited by 38
Zheng, H., Zou, W., Shen, J., Xu, L., Wang, S., Fu, Y.-X., & Fan, W. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0300 · Cited by 28
Ma, T.-L., Zhu, P., Ke, Z.-R., Chen, J.-X., Hu, Y.-H., & Xie, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.891313 · Cited by 9
Pan, X., Gao, T., & Wang, B. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01520-9 · Cited by 2
“Furthermore, MSCs have been demonstrated to increase the phagocytic capacity and infection susceptibility of macrophages [85, 145].”
Metadata
- Authors
- Maggini, J., Mirkin, G., Bognanni, I., Holmberg, J., Piazzón, I. M., Nepomnaschy, I., Costa, H., Cañones, C., Raiden, S., Vermeulen, M., & Geffner, J. R.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-02-16
- Volume
- 5
- Issue
- 2
- Pages
- e9252
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1991460349
- Cited by
- 567
- References
- 53
- FWCI
- 15.68
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.